Related Experiment Video
Updated: Jul 17, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Obesity: a complicating factor for sedation in children
1Division of Diagnostic and Surgical Sciences, School of Dentistry, University of California, Los Angeles, USA. subakertt@yahoo.com
Childhood obesity presents unique challenges in pediatric dental sedation, increasing risks for respiratory and gastrointestinal issues. Careful drug selection and dosing are crucial for safe and effective pharmacosedation in obese children.
Area of Science:
- Pediatric Dentistry
- Anesthesiology
- Public Health
Background:
- Childhood obesity is a growing public health concern in the United States.
- Obesity in children presents unique physiological challenges impacting medical procedures.
- Dental sedation for pediatric patients requires careful consideration of patient-specific factors.
Purpose of the Study:
- To review the impact of childhood obesity on pharmacosedation in pediatric dentistry.
- To offer recommendations for managing obese pediatric patients undergoing dental sedation.
Main Methods:
- Literature review focusing on the physiological effects of obesity in children.
- Analysis of pharmacosedation principles and drug dosing in relation to body mass.
- Identification of potential complications and risk mitigation strategies.
Main Results:
- Obese children face increased risks of respiratory complications (restrictive lung disease, obstructive sleep apnea) and gastrointestinal issues (aspiration).
- Standard drug dosing based on total body weight may lead to oversedation; lean body mass dosing may cause undersedation and reduced effect duration.
- Cardiovascular risks like hypertension are more prevalent in obese pediatric patients.
Conclusions:
- Pharmacosedation in obese pediatric dental patients requires specialized management strategies.
- Adjusted drug selection, precise dosing (considering lean body mass), and vigilant patient positioning are essential.
- Minimizing risks involves avoiding certain medications like opioids and implementing enhanced monitoring protocols.
Related Concept Videos
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Obesity
Drug Dosing: Infants and Children
